Work

Survival after Complete Response to Treatment with Laromustine (CLORETAZINE®) in Elderly Patients with De Novo Poor Risk Acute Myelogenous Leukemia (AML).

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.940.940

Authors: Susan O’Brien, Gary Schiller, Robert Kenneth Stuart, Diana Hudak, Francis Giles

Institutions: The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, Medical University of South Carolina, Vion Pharmaceuticals (United States), The University of Texas at San Antonio Health Science Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2536107186

FWCI: 0.647

Cites:

Cited by: 3

Related to: 10